AI assistant
NextTrip, Inc. — Board/Management Information 2022
Apr 4, 2022
34837_rns_2022-04-04_0afc1d2d-a7de-4b51-8271-8e7505d8f1e1.zip
Board/Management Information
Open in viewerOpens in your device viewer
Field: Rule-Page
Field: /Rule-Page
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): April 1, 2022
SIGMA LABS, INC.
(Exact name of registrant as specified in its charter)
| Nevada | 001-38015 | 27-1865814 |
|---|---|---|
| (State | ||
| or other jurisdiction of incorporation | ||
| or organization) | (Commission File | |
| Number) | (I.R.S. | |
| Employer Identification | ||
| No.) |
3900 Paseo del Sol
Santa Fe , New Mexico 87507
(Address of Principal Executive Offices) (Zip Code)
Registrant’s telephone number, including area code: (505) 438-2576
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ☐ | Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| --- | --- |
| ☐ | Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title
of each class | Trading
Symbol(s) | Name
of each exchange on which registered |
| --- | --- | --- |
| Common
Stock, par value $0.001 per share | SGLB | The
NASDAQ Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Field: Rule-Page
Field: /Rule-Page
Field: Page; Sequence: 1
Field: /Page
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Effective April 1, 2022, Jacob Brunsberg, age 35, the current President and Chief Operating Officer of Sigma Labs, Inc. (“Sigma,” or the “Company”), will become Sigma’s President, Chief Executive Officer and principal executive officer and will no longer serve as Chief Operating Officer. Also effective April 1, Mr. Brunsberg was appointed to serve as a Class II director on the Board. Prior to joining Sigma in September 2021 as Senior Vice President responsible for leading the Company’s strategic relationships, product management and marketing programs, Mr. Brunsberg was a P&L leader for General Electric’s Binder Jet Technology unit with management responsibility for strategy, development, commercialization, and overall business performance. He has a degree in material science from the University of Wisconsin.
There are no arrangements or understandings between Mr. Brunsberg and any other persons pursuant to which he was chosen as President, Chief Executive Officer and principal executive officer of the Company. There are no family relationships between Mr. Brunsberg and any of the Company’s directors, executive officers or persons nominated or chosen by the Company to become a director or executive officer. Mr. Brunsberg is not a party to any current or proposed transaction with the Company for which disclosure is required under Item 404(a) of Regulation S-K, and Mr. Brunsberg’s employment agreement with the Company remains in place in accordance with its terms.
Mr. Brunsberg replaces Mark Ruport, who resigned from his positions as Chief Executive Officer and principal executive officer of the Company effective April 1, 2022. Mr. Ruport remains a director of the Company and was appointed to replace the current Chairman of the Board, John Rice, who will continue to serve as a director. Mr. Ruport will continue to be compensated under his current terms of employment through May 31, 2022, for his services during this leadership transition. Beginning June 1, 2022, Mr. Ruport will be entitled to be compensated as a non-employee director under the Company’s non-employee director compensation program, as it may be adjusted from to time.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
| Number | Description |
|---|---|
| 99.1 | Press Release of Sigma Labs, Inc., dated April 4, 2022 |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
Field: Page; Sequence: 2
Field: /Page
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date:
April 4, 2022 | |
| --- | --- |
| By: | /s/
Jacob Brunsberg |
| Name: | Jacob
Brunsberg |
| Title: | President
and Chief Executive Officer |
Field: Page; Sequence: 3; Options: Last
Field: /Page